Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein E genotype predicts cardiovascular endpoints in dialysis patients with type 2 diabetes mellitus.

Atherosclerosis - 1 Jan 2010

Winkler Karl, Hoffmann Michael M, Krane Vera, März Winfried, Drechsler Christiane, Wanner Christoph

Abstract excerpt

OBJECTIVE: Cardiovascular disease (CVD) is the leading cause of death in patients with type 2 diabetes (T2DM) and end-stage renal disease (ESRD). Lipid metabolism is influenced by environmental and genetic factors. Among the latter, the apolipoprotein E (apoE) genotype is known to be associated with CVD risk and thus may affect cardiovascular outcome. METHODS AND RESULTS: Based on the German Diabetes and Dialysis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Aged

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Diabetes Mellitus, Type 2

Share to Kidney Failure, Chronic

Share to Prognosis

Share to Randomized Controlled Trials as Topic

Share to Renal Dialysis

Source

Identifiers

PMID: 19628211
DOI: 10.1016/j.atherosclerosis.2009.06.036

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein E genotype predicts cardiovascular endpoints in dialysis patients with type 2 diabetes mellitus.PMID 19628211Read ↗

Association of APOE polymorphisms with diabetes and cardiometabolic risk factors and the role of APOE genotypes in response to anti-diabetic therapy: results from the AIDHS/SDS on a South Asian population.Semantic proximity Read ↗

The influence of serum apolipoprotein E concentration and polymorphism on serum lipid parameters in hemodialysis patients.Semantic proximity Read ↗

Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease.Semantic proximity Read ↗

Apolipoprotein E levels and apolipoprotein E genotypes in incident cardiovascular disease risk in subjects of the Prevention of Renal and Vascular End-stage disease study.Semantic proximity Read ↗

The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4.Semantic proximity Read ↗

Rationale and study design of the prospective, longitudinal, observational cohort study "rISk strAtification in end-stage renal disease" (ISAR) study.Semantic proximity Read ↗

Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.Semantic proximity Read ↗

RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients.Semantic proximity Read ↗

End‐stage renal disease – not an equal opportunity disease: the role of genetic polymorphismsSemantic proximity Read ↗

Apo E gene polymorphism on development of diabetic nephropathy.Semantic proximity Read ↗

Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature.Semantic proximity Read ↗

Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.